# 10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication

> **NCT03134378** · PHASE4 · UNKNOWN · sponsor: **Indonesia University** · enrollment: 73 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Rabeprazole Sodium 20mg
- **DRUG:** Clarithromycin 500mg
- **DRUG:** Amoxicillin 500 Mg

## Key facts

- **NCT ID:** NCT03134378
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10-03
- **Primary completion:** 2017-05-05
- **Final completion:** 2017-05-12
- **Target enrollment:** 73 (ESTIMATED)
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03134378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03134378, "10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03134378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*